TSHA — Taysha Gene Therapies Share News
0.000.00%
- $1.22bn
- $809.38m
- $9.77m
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)
U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple
Gene therapy makers slide on reports that FDA official Peter Marks resigns
U.S. STOCKS ON THE MOVE-Gold miners, Hut 8, Mr Cooper Group
Drugmakers tumble on reports FDA's top vaccine regulator set to leave (updated)
U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers
Biotech stocks tumble on reports FDA's top vaccine regulator to leave
Gene therapy makers slide on reports that FDA official Peter Marks resigns
Brief: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
U.S. RESEARCH ROUNDUP-AT&T, ATI, California Resources
U.S. STOCKS ON THE MOVE-Altimmune, General Mills, Whirlpool
U.S. STOCKS ON THE MOVE-Grindr, FedEx, Moderna
Taysha Gene Therapies tumbles after $75 mln equity offering priced
U.S. STOCKS ON THE MOVE-Apple, SolarEdge Technologies, Taysha Gene Therapies
Taysha Gene Therapies slides after equity offering launch
U.S. STOCKS ON THE MOVE-Chemours, Lucid, OppFi